The global vitamin
D testing
market is expected to reach USD 1.1 billion by
2025, according to a new report by Grand View Research, Inc.
Global increase in geriatric population as well as cases of
chronic illnesses is likely to drive the market during the
forecast period.
Furthermore, increase in investment for development and
commercialization of various accurate, innovative, and
easy-to-use tests by various market players and governments is
likely to drive the market growth. For instance,
in January
2017, Future Diagnostics and DIA source received a grant
of EUR 1.4
million from the European Commission to develop a
unique CE-marked assay that can measure the level of free vitamin
D (25OHD) in the body. In addition, this assay will assist in
early recovery of patients suffering from vitamin D deficiency by
providing optimized treatment, offering an opportunity to save
treatment costs.
Vitamin D assay measures the level of vitamin D in two forms.
Hence, the market has been divided by two major types of tests,
namely 25-Hydroxy Vitamin D test and 1, 25-Dihydroxy vitamin
test.
The 5-hydroxy vitamin D tests or assay segment dominated in 2016
due to its greater ability to identify bone malformations,
softness, weakness, and fractures in adults. Its domination is
likely to continue in the forecast period as well.
Browse full research report with TOC
on "Vitamin
D Testing Market Analysis By Type of Test (25-Hydroxy Vitamin D
Tests; 1, 25-Dihydroxy Vitamin D Tests), Region (North
America, Europe, Asia
Pacific, South & Central America, MEA),
And Segment Forecasts, 2014 -
2025" at:http://www.grandviewresearch.com/industry-analysis/vitamin-d-testing-market
Further key findings from the report
suggest:
- Rising incidence of chronic illnesses and growing geriatric
population are expected to propel the growth of the market with a
CAGR of 9.4% from 2017 to 2025
- 5-hydroxy vitamin D test segment accounted for the largest
share and is anticipated to witness strong growth during the
forecast period. This can be attributed to the availability of
several commercial products, ongoing research in the field, and
the ability to accurately detect bone malformations.
- Geographically, North America held
the largest share in 2016. It is expected to maintain its
dominance during the forecast period due to higher awareness
about screening, higher healthcare expenditure as compared to
other developing countries, and local presence of market players.
- The industry in Asia Pacific is
projected to witness substantial growth over the next decade
owing to growing investments by several market players in the
region, growing healthcare expenditure, and recent
commercialization of tests in major markets, such
as Japan and China
- Some of the key players are Abbott Laboratories; F.
Hoffmann-La Roche Ltd.; Hologic, Inc.; Siemens Corporation;
Danaher Corporation; Quest Diagnostics, Inc.; bioMérieux SA; and
DiaSorin S.p.A.
Browse related reports by Grand View
Research:
Grand View Research has segmented the global vitamin D
testing market on the basis of type of test and
region:
-
Type of Test Outlook (Revenue, USD Million, 2014 -
2025)
- 25-Hydroxy Vitamin D Tests
- 1, 25-Dihydroxy Vitamin D Test
-
Regional Outlook (Revenue, USD Million, 2014 -
2025)
-
North
America
-
Europe
-
Asia
Pacific
- Central & South America
-
Middle
East & Africa
Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of
California and headquartered in San Francisco.
The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make
informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of
industries, from technology to chemicals, materials and
healthcare.
